GeneDx Holdings Corp. WGS
Set alert
64.09 USD -4.97 -7.20%
At close
64.90 +0.81 +1.26%
Pre-market · Nov 3, 4:00 AM ET
63.61 Day range 69.53
32.21 52-week range 170.87
- YTD
- -50.72%
- 1 year
- -53.19%
- Open
- 69.15
- Prev close
- 69.06
- Mkt cap
- 1.91B
- Vol
- 1.15M
- Avg vol
- 764.45K
- EPS
- -3.63
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 63.61
- High
- 69.53
- Forward P/E
- 53.47
- Beta
- 1.99
- Short ratio
- 7.23
- Inst. own
- 108.66%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 79.04
- 200-d avg
- 71.93
- 1y target
- 93.50
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 93.50 +45.9% upside
Now 64.09
- Target (low)
- 83.00
- Target (mean)
- 93.50
- Target (high)
- 103.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy1
- Buy7
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.07286 | 0.07 – 0.08 | 0.49 | -85.1% | 122.92M | +5.3% | 7 |
| Next quarter | 0.32 | 0.21 – 0.50 | 0.14 | +128.6% | 142.65M | +17.9% | 7 |
| Current year | 0.13143 | 0.02 – 0.32 | 1.40 | -90.6% | 481.84M | +12.7% | 7 |
| Next year | 1.20 | 0.44 – 2.00 | 0.13143 | +812.0% | 598.96M | +24.3% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 4, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 4, 2026 | BTIG | Reiterated | Buy | Buy |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 23, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| May 5, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 5, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 5, 2026 | BTIG | Maintained | Buy | Buy |
| Apr 20, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 24, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 24, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 9, 2026 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Dec 22, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 15, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Dec 12, 2025 | BTIG | Maintained | Buy | Buy |
| Nov 4, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 29, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 29, 2025 | Guggenheim | Maintained | Buy | Buy |
| Oct 29, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 22, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 20, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Sep 11, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 4, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 30, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 9, 2025 | Piper Sandler | Initiated | — | Overweight |
| Jun 30, 2025 | Guggenheim | Maintained | Buy | Buy |
| May 9, 2025 | Jefferies | Upgrade | Hold | Buy |
| May 1, 2025 | TD Securities | Maintained | Buy | Buy |